Nuclera closes $75 million USD financing

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million).

Positive Surgical Margins More Likely Among Black Men With Oral Cancer

MONTREAL –The rate of positive surgical margins was higher in Black men with oral cavity squamous cell carcinoma (OCSCC) than others, a retrospective cohort study

July 12, 2023

New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

Study evaluates the effectiveness of the XBB.1.5 COVID-19 vaccine in reducing hospitalizations and ICU admissions among vaccinated adults aged 60 and over in the Netherlands,

December 18, 2023

To rebuild trust in public health: Better communication, fewer mandates, and small wins

It’s no surprise in today’s corrosive political environment that trust in government is near an all-time low. That’s a big problem. Communities with more trust

April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.